Learn about the latest advances in inflammatory bowel disease (IBD) and advanced endoscopic procedures from the experts of the Dr. Henry D. Janowitz Division of Gastroenterology at Mount Sinai. Ever since Mount Sinai physician Burrill Crohn, MD, and colleagues described the condition now known as Crohn’s disease, Mount Sinai gastroenterologists have been on the cutting edge of diagnosing and treating IBD and other gastrointestinal disorders. Bruce Sands, MD, MS is the Chief of the Division of Gastroenterology and Director of the Digestive Disease Institute. A longtime advocate for the continued translational research in Crohn's disease and ulcerative colitis, Dr. Sands is widely recognized for his innovative treatment of IBD and for his clinical investigations of new therapeutics. Our Susan and Leonard Feinstein IBD Clinical Center, led by Jean-Frederic Colombel, MD, and Marla Dubinsky, MD, is at the forefront of research into the causes of IBD and leads the field in clinical trials that have advanced patient care. Additionally, at our Center for Advanced Colonoscopy and Therapeutic Endoscopy at Sinai (CACTES), led by Christopher DiMaio, MD, our physicians are pioneering new tools and techniques to identify, diagnose, and treat the most complex digestive disorders.
The Gastroenterology & GI Surgery Department at the Mount Sinai Hospital is proud to be ranked No. 13 in the nation by U.S. News & World Report Best Hospitals for 2022-23.
Featured Content |view more
Targeting Disease Prediction and Prevention: The New Frontier in IBD
Mount Sinai researchers have found strong evidence that before the first symptoms of Crohn’s disease and ulcerative colitis occur, there’s a preclinical phase in which immune and inflammatory pathways are already altered.
Why a Colonoscopy Is the Best Way to Detect and Prevent Colon Cancer
A study published last September in the New England Journal of Medicine appeared to question the benefits of colonoscopies. But many experts say they remain “the gold standard” to detect and prevent colon cancer.
Gastroenterology, GI Surgery and Liver Diseases Specialty Report 2023
In this report, you’ll learn about our discovery that Crohn’s disease and ulcerative colitis have a years-long preclinical phase in which immune and inflammatory pathways are measurably altered.
Mount Sinai IBD Course for Ukraine
In war-torn Ukraine, doctors are struggling to deliver quality care to the sick and are unable to travel for educational opportunities due to war-time restrictions.
New Head-to-Head Trial of Major Biologics Is an Eye-Opener for Crohn’s Disease Therapy
A head-to-head randomized controlled trial found similar remission rates for two leading biologic therapies for Crohn's disease: ustekinumab and adalimumab.
Mount Sinai Researchers Start to Unravel B Cell Dysregulation in Ulcerative Colitis
Mount Sinai-led researchers have discovered for the first time a highly dysregulated B cell response in ulcerative colitis that opens the door to potential new biomarkers and therapeutic strategies for it as well as other types of inflammatory bowel disease.
New Interim Head of Colorectal Surgery Is a Pioneer in Treating Rectal Tumors
Patricia Sylla, MD, was recently named Interim Chief of the Division of Colorectal Surgery at Mount Sinai Health System.
Leaving an Imprint on Two Decades of Gastroenterology Fellows
Steven Itzkowitz, MD, stepped down in July 2022 after 23 years as Mount Sinai's Gastroenterology Fellowship Program Director.
Aggressive Surveillance Paves the Way for Early Detection of Pancreatic Cancer
Recent studies underscore the benefit of high-risk pancreatic surveillance programs that have helped push three-year survival rates as high as 85 percent in some cases, in large part by catching a higher proportion of malignant lesions ...
Mount Sinai’s Interventional Endoscopy Team Underscores Its Support for Gender Equity
Diversity, equity, and inclusion are integral aspects of the academic and clinical work performed by the Mount Sinai Health System's endoscopy team. They are also critical to providing the best possible patient care.
Stem Cell Transplants Prove Effective for Patients With Severe Crohn’s Disease
A clinical study of autologous stem cell transplantation for severe Crohn's disease is offering the sickest of patients a transformative therapy that is achieving remarkable early results in this group for whom nothing in the past has worked.
Targeting New York’s Vast Hepatitis B Population With Universal Testing and Vaccination
Mount Sinai has launched a system of digital alerts that appear on the screens of primary care physicians when a patient in their offices is a candidate for testing, vaccination, or treatment for hepatitis B.
NASH Center of Excellence Wins Grants for Two Initiatives
Two new grants from Pfizer will help Mount Sinai educate primary care providers on how to identify at-risk patients and address inequities in diagnosis and care of nonalcoholic steatohepatitis.
Mount Sinai Study finds Advanced Radiotherapy Offers Safe, Effective Treatment for Patients with Early-Stage Liver Cancer
An advanced radiotherapy technique called radiation segmentectomy may be effective against very early to early-stage hepatocellular carcinoma (HCC), a type of liver cancer that cannot be treated surgically or thermally.
Bringing Ultrasound to the Bedside to Rapidly Diagnose and Treat IBD
The Susan and Leonard Feinstein Inflammatory Bowel Disease Clinical Center at Mount Sinai is the only center in the country that is currently using ultrasound to monitor inflammation in inflammatory bowel disease patients.
Carving Out a New Care Pathway for Patients With IBD and Arthritis
A collaborative model between Gastroenterology and Rheumatology in the Department of Medicine at Mount Sinai is providing patients with IBD and arthritis a level of care few clinics in the world can offer, and researchers with a springboard ...
Providing Much-Needed Support for Women After J-Pouch Surgery
Mount Sinai Health System, which pioneered and continues to refine the technique of J-pouch surgery, has now created a Comprehensive Pouch Program to closely monitor patients after surgery, ensuring continuous, hands-on care designed to ...
Mount Sinai Introduces Two Novel Endoscopy Procedures
Mount Sinai’s interventional endoscopy team continues to lead the field in innovation with the recent introduction of two novel procedures that are dramatically advancing treatment for patients with achalasia, necrotizing pancreatitis, ...
Genetic Studies Identify New Pathways in Inflammatory Bowel Disease
Two new Mount Sinai studies have defined novel approaches for treating Crohn’s disease and ulcerative colitis (UC).
New Center of Excellence Focuses on NASH Treatment and Research
The Mount Sinai Division of Liver Diseases has built on its nationally recognized expertise in fibrosis and fibrotic pathways to create the NASH Center of Excellence, concentrating under one umbrella a rich diversity of clinical and research ...
Gender Inequities in Gastroenterology Spur Efforts for Change
While gastroenterology is historically a male-dominated field, the ranks of female professionals are growing.
Intestinal Ultrasound Ushers In New Era of IBD Treatment
Intestinal ultrasound to monitor ulcerative colitis and Crohn's disease has become the standard of care in Canada and many parts of Europe, but has never gained a foothold in the United States.
Registry Tracks How IBD Drugs Interact With COVID-19
A research database known as SECURE-IBD provides a quick and robust source of information to clinicians around the world about the use of IBD therapies like corticosteroids and the widely prescribed tumor necrosis factor (TNF) antagonists ...
Intestinal Study Yields Insights Into Persistence of SARS-CoV-2
SARS-CoV-2 has a spike protein that tethers itself to angiotensin converting enzyme 2 (ACE2) to gain entry to cells, and the intestinal tract has the highest expression of ACE2 in the body—even higher than in the lungs.
Novel Understanding of Fecal Microbiota Could Make Transplantation Safer and More Precise
Researchers used whole-genome sequencing to identify 42 species of fecal microbiota that were especially likely to engraft successfully.
Gastroenterology, GI Surgery and Liver Diseases Specialty Report 2022
Collaboration—among specialists in different disciplines, and between clinicians and bench scientists—is a hallmark of the Mount Sinai Health System and our Dr. Henry D. Janowitz Division of Gastroenterology. That approach is spotlighted ...
Cholangiocarcinoma: Bridging the Gap Between the Clinic and the Laboratory
This presentation highlights the epidemiology and current management of cholangiocarcinoma, as well as future therapeutic approaches
Jerry Waye, MD Endoscopy Conference
For the past four decades, the Jerry Waye, MD, Endoscopy Conference has featured case presentations at a weekly gathering of gastroenterology fellows and clinical staff at Mount Sinai.
SARS-CoV-2 Vaccination for Patients with Inflammatory Bowel Diseases: Recommendations from an International Consensus Meeting
COVID-19 Vaccines for IBD Patients: International Consensus
Pediatric Therapeutic Endoscopy Program at Mount Sinai
Dr. J. Antonio Quiros discusses the Pediatric Therapeutic Endoscopy Program at Mount Sinai
Joanne Lai, MD, Discusses the Pediatric Gastroenterology Program at Mount Sinai Doctors-Long Island
Joanne Lai, MD, discusses the range of pediatric gastroenterology services offered at Mount Sinai Doctors-Long Island.
Gastroenterology, GI Surgery and Liver Diseases Specialty Report 2021
We launched a database called SECURE-IBD that has already yielded the insight that TNF antagonists appear to be a low-risk IBD therapy where COVID-19 is concerned, and another study, called ICARUS, intended to explore the seroprevalence ...
The Mount Sinai Hospital Included in New Ranking of Best Specialized Hospitals from Newsweek
Gastroenterology and Mount Sinai Heart are among the specialties recognized at The Mount Sinai Hospital in Newsweek’s “The World’s Best Specialized Hospitals 2021.”
Icahn School of Medicine at Mount Sinai Ranks No. 3 Globally for “Best University for Gastroenterology and Hepatology”
The Icahn School of Medicine at Mount Sinai was ranked No. 3 in the world in U.S. News & World Report “Best University for Gastroenterology and Hepatology.” The Seventh Annual U.S. News & World Report “Best Global Universities” rankings ...
David Dunkin, MD, Discusses Pediatric Gastroenterology Services at Mount Sinai-Brooklyn Heights
Listen as David Dunkin, MD, discusses the advanced and innovative pediatric gastroenterology care provided at Mount Sinai Doctors-Brooklyn Heights
Case Based Question & Answer Session: Liver Diseases
Case Based Question & Answer Session on Liver Pathology, Abnormal LFTs and Jaundice, Hepatitis B, Hepatitis C, Autoimmune Hepatitis, Alcoholic and Nonalcoholic Liver Disease, Cholestatic Liver Disease, Liver Tumors, Cirrhosis, Portal Hypertension ...
Deirdre J. Cohen, MD, MS, Appointed as Director of Gastrointestinal Oncology Program of Mount Sinai Health System
Deirdre J. Cohen, MD, MS, an expert in pancreatic and other gastrointestinal cancers, has joined Mount Sinai Health System as Director of the Gastrointestinal Oncology Program
The Innovation Cafe Presents Trellus Health: Transforming IBD Patient Care
The founders of Trellus Health, LLC, discuss their resiliency-driven approach to inflammatory bowel disease treatment utilizing digital tools, care coordination, and support
Advanced Endoscopy and Inflammatory Bowel Disease
Christopher DiMaio, MD, discusses advanced therapeutic endoscopic procedures that can provide an alternative to surgery for gastrointestinal conditions.
COVID-19: IBD Update From the Front Lines
A new database tracks risk factors for IBD patients who have COVID-19